Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neotility: CoQ10 in Idiopathic Infertility
NCT03104998Phase 4Withdrawn
- Sponsor
- PharmEvo
- Start
- Aug 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Coenzyme Q10 mucoadhesive tablets in unexplained infertility, sponsored by PharmEvo. Primary endpoint: Change in semen parameters at 26 weeks. Planned start Aug 2017; status: withdrawn.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
unexplained infertility
Beyond the preview
Go deeper on NCT03104998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104998.